- Home
- HSIC vs FUTU Comparison
HSIC vs FUTU Comparison
Compare HSIC & FUTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSIC
- FUTU
- Stock Information
- Founded
- HSIC 1932
- FUTU 2011
- Country
- HSIC United States
- FUTU Hong Kong
- Employees
- HSIC N/A
- FUTU N/A
- Industry
- HSIC Medical Specialities
- FUTU Investment Bankers/Brokers/Service
- Sector
- HSIC Health Care
- FUTU Finance
- Exchange
- HSIC Nasdaq
- FUTU Nasdaq
- Market Cap
- HSIC 9.0B
- FUTU N/A
- IPO Year
- HSIC 1995
- FUTU 2019
- Fundamental
- Price
- HSIC $73.42
- FUTU $149.99
- Analyst Decision
- HSIC Buy
- FUTU Strong Buy
- Analyst Count
- HSIC 10
- FUTU 4
- Target Price
- HSIC $79.70
- FUTU $136.23
- AVG Volume (30 Days)
- HSIC 1.6M
- FUTU 2.3M
- Earning Date
- HSIC 08-05-2025
- FUTU 08-19-2025
- Dividend Yield
- HSIC N/A
- FUTU 1.30%
- EPS Growth
- HSIC 8.11
- FUTU 58.31
- EPS
- HSIC 3.21
- FUTU 6.00
- Revenue
- HSIC $12,669,000,000.00
- FUTU $1,788,948,850.00
- Revenue This Year
- HSIC $4.28
- FUTU $48.73
- Revenue Next Year
- HSIC $3.57
- FUTU $9.97
- P/E Ratio
- HSIC $22.88
- FUTU $24.98
- Revenue Growth
- HSIC 1.75
- FUTU 54.51
- 52 Week Low
- HSIC $60.56
- FUTU $51.80
- 52 Week High
- HSIC $82.49
- FUTU $150.01
- Technical
- Relative Strength Index (RSI)
- HSIC 55.47
- FUTU 77.46
- Support Level
- HSIC $73.02
- FUTU $117.78
- Resistance Level
- HSIC $75.76
- FUTU $150.01
- Average True Range (ATR)
- HSIC 1.36
- FUTU 5.85
- MACD
- HSIC -0.01
- FUTU 2.52
- Stochastic Oscillator
- HSIC 52.24
- FUTU 99.96
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.